欧洲 · 通讯社与实时数据 · Reuters US Markets

Obesity drug developer Corxel to go public in US via SPAC deal

来源：Reuters US Markets · 英国 11 小时前

Obesity drug developer Corxel Pharmaceuticals will go public in the US through a merger with special purpose acquisition company Amanat Acquisition ‌Corp , the companies…

在 Reuters US Markets 阅读全文登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.reuters.com)

Obesity drug developer Corxel to go public in US via SPAC deal

推荐阅读

Fed expected to hold rates amid accelerating inflation ahead of November US midterms

Japanese companies compensate users as cyberattacks buffet economy

FTSE 100 rises as falling oil prices boost risk appetite

Saudi Arabia to store oil in Singapore to bolster Asia supply security

Fed to hit pause on rate hikes, but maybe not for long

Fed to hit pause on rate hikes, but maybe not for long

Obesity drug developer Corxel to go public in US via SPAC deal

分享

推荐阅读

Fed expected to hold rates amid accelerating inflation ahead of November US midterms

Japanese companies compensate users as cyberattacks buffet economy

FTSE 100 rises as falling oil prices boost risk appetite

Saudi Arabia to store oil in Singapore to bolster Asia supply security

Fed to hit pause on rate hikes, but maybe not for long

Fed to hit pause on rate hikes, but maybe not for long